Hepatitis B virus infection and intrahepatic cholangiocarcinoma in Korea: A case-control study

被引:166
作者
Lee, Tae Y. [1 ]
Lee, Sang S. [1 ]
Jung, Seok W. [2 ]
Jeon, Seong H. [3 ]
Yun, Sung-Cheol [4 ]
Oh, Hyoung-Chul [1 ]
Kwon, Seunghyun [1 ]
Lee, Sung K. [1 ]
Seo, Dong W. [1 ]
Kim, Myung-Hwan [1 ]
Suh, Dong J. [1 ]
机构
[1] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Internal Med, Seoul 138736, South Korea
[2] Univ Ulsan, Coll Med, Ulsan Univ Hosp, Dept Internal Med, Ulsan, South Korea
[3] Univ Ulsan, Coll Med, Asan Med Ctr, Hlth Promot Ctr, Seoul 138736, South Korea
[4] Univ Ulsan, Coll Med, Dept Prevent Med, Seoul 138736, South Korea
关键词
D O I
10.1111/j.1572-0241.2008.01796.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
OBJECTIVES: There is a wide variation in risk factors for intrahepatic cholangiocarcinoma (ICC) among various populations. Several studies have suggested that hepatitis C virus (HCV) infection may play a role in the development of ICC, whereas the role of hepatitis B virus (HBV) infection is less clear. METHODS: To determine whether HBV or HCV infection is a risk factor of ICC, we compared baseline demographic and clinical factors in 622 patients diagnosed between 2000 and 2004 with histologically confirmed ICC and 2,488 healthy controls, matched 4:1 with ICC patients for sex and year of birth. RESULTS: HBV infection (odds ratio [OR] 2.3, 95% confidence interval [CI] 1.6-3.3), but not HCV infection, was significantly related to ICC. Other significant risk factors for ICC included liver cirrhosis (OR 13.6), heavy alcohol consumption (OR 6.6), diabetes (OR 3.2), Clonorchis sinensis infection (OR 13.6), hepatolithiasis (OR 50.0), and choledochal cysts (OR 10.7). CONCLUSIONS: Our results indicate that development of ICC seems to be more closely related to HBV infection than to HCV infection in Korea, where both HBV and ICC are endemic.
引用
收藏
页码:1716 / 1720
页数:5
相关论文
共 32 条
[1]  
Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO
[2]  
2-S
[3]   Intrahepatic cholangiocarcinoma and hepatitis C and B virus infection, alcohol intake, and hepatolithiasis: a case-control study in Italy [J].
Donato, F ;
Gelatti, U ;
Tagger, A ;
Favret, M ;
Ribero, ML ;
Callea, F ;
Martelli, C ;
Savio, A ;
Trevisi, P ;
Nardi, G .
CANCER CAUSES & CONTROL, 2001, 12 (10) :959-964
[4]   Hepatitis B virus and intrahepatic cholangiocarcinoma [J].
Gatselis, Nikolaos K. ;
Tepetes, Konstantinos ;
Loukopoulos, Argirios ;
Vasiou, Katerina ;
Zafiriou, Athanasios ;
Gioti, Chrisoula ;
Dalekos, Georgios N. .
CANCER INVESTIGATION, 2007, 25 (01) :55-58
[5]   Cholangiocarcinoma [J].
Khan, SA ;
Thomas, HC ;
Davidson, BR ;
Taylor-Robinson, SD .
LANCET, 2005, 366 (9493) :1303-1314
[6]  
Kobayashi M, 2000, CANCER, V88, P2471, DOI 10.1002/1097-0142(20000601)88:11<2471::AID-CNCR7>3.0.CO
[7]  
2-T
[8]   The risk of liver and bile duct cancer in patients with chronic viral hepatitis, alcoholism, or cirrhosis [J].
Kuper, H ;
Ye, WM ;
Broomé, U ;
Romelsjö, A ;
Mucci, LA ;
Ekbom, A ;
Adami, HO ;
Trichopoulos, D ;
Nyrén, O .
HEPATOLOGY, 2001, 34 (04) :714-718
[9]   Cholangiocarcinoma [J].
Lazaridis, KN ;
Gores, GJ .
GASTROENTEROLOGY, 2005, 128 (06) :1655-1667
[10]   Epidemiological findings of hepatitis B infection based on 1998 National Health and Nutrition Survey in Korea [J].
Lee, DH ;
Kim, JH ;
Nam, JJ ;
Kim, HR ;
Shin, HR .
JOURNAL OF KOREAN MEDICAL SCIENCE, 2002, 17 (04) :457-462